IP Library Granted Patent US 12,226,578
Granted Patent B2
US 12,226,578 · App. 18/340,154 · Granted Feb 18, 2025

Patient interface with a seal-forming structure having varying thickness

Inventors: Matthew Eves (Sydney, AU); Lemmy Nga (Sydney, AU); Gerard Michael Rummery (Woodford, AU); Rupert Christian Scheiner (Sydney, AU)
Assignee: ResMed Pty Ltd
A61M16/0622A61M16/0066A61M16/06A61M16/0611A61M16/0616A61M16/0633A61M16/0666A61M16/0683A61M16/0825A61M16/0069A61M16/0875A61M16/1055A61M16/107A61M16/109A61M16/1095A61M16/16A61M2202/0225A61M2205/42A61M2207/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,226,578
App. No.
18/340,154
Granted
Feb 18, 2025
Kind
B2
Abstract

A cushion assembly for a patient interface including an elastomeric seal-forming structure that is shaped to be bisected by a sagittal plane having a line that is tangent to the elastomeric seal-forming structure at a superior tangent point and at an inferior tangent point. A saddle-shaped superior region of the elastomeric seal-forming structure straddles the sagittal plane and includes the superior tangent point. The elastomeric seal-forming structure transitions in a cylinder-shaped superior region from the saddle-shaped region to a dome-shaped superior region offset from the sagittal plane. In addition, an elastomeric wall thickness of the elastomeric seal-forming structure is greater in the cylinder-shaped superior region than in the saddle-shaped superior region and the dome-shaped superior region.

Claims (66)

1. A cushion assembly for a patient interface for sealed delivery of a flow of air at a continuously positive pressure with respect to ambient air pressure to an entrance to a patient's airways including at least entrance of the patient's nares, wherein the patient interface is configured to maintain a therapy pressure in a range of about 4 cmH2O to about 30 cmH2O above ambient air pressure in use, throughout the patient's respiratory cycle, while the patient is sleeping, to ameliorate sleep disordered breathing, the cushion assembly comprising:

an elastomeric support portion;

an elastomeric seal-forming structure supported by the elastomeric support portion and being shaped to be bisected by a sagittal plane that includes a line tangent to the elastomeric seal-forming structure at a superior tangent point and at an inferior tangent point, the elastomeric support portion being more rigid than the elastomeric seal-forming structure, the elastomeric seal-forming structure comprising a first compliant region that includes the superior tangent point and a second compliant region separated from the first compliant region by a support region that is more rigid than the first and second compliant regions;

a blowout prevention system comprising a first end that is anchored to the elastomeric support portion and a second end that is a continuation of the elastomeric seal-forming structure at the second compliant region; and

a chamber defined by the elastomeric support portion and the elastomeric seal-forming structure,

wherein the elastomeric seal-forming structure comprises an inner surface forming a boundary for the chamber and comprises an outer surface opposite the inner surface,

and

wherein the more rigid support region extends to and is anchored by the elastomeric support portion, and wherein an elastomeric wall thickness in the more rigid support region is invariable.

2. The cushion assembly of claim 1 , wherein an elastomeric wall thickness of the elastomeric seal-forming structure in the first compliant region is the same as an elastomeric wall thickness of the elastomeric seal-forming structure in the second compliant region.

3. The cushion assembly of claim 1 , wherein the first compliant region of the elastomeric seal-forming structure extends to the elastomeric support portion, and the second compliant region of the elastomeric seal-forming structure does not extend to the elastomeric support portion.

4. The cushion assembly of claim 1 , wherein the blowout prevention system is in the form of a tubular structure.

5. The cushion assembly of claim 1 , wherein the more rigid support region is positioned at a location that is superior to the blowout prevention system.

6. The cushion assembly of claim 1 , wherein the elastomeric seal-forming structure further comprises an inferior region that includes the inferior tangent point, and wherein the elastomeric wall thickness of the elastomeric seal-forming structure in the inferior region is the same as the elastomeric wall thickness in the first compliant region.

7. The cushion assembly of claim 6 , wherein the elastomeric seal-forming structure further comprises a first intermediate region that extends from the second compliant region to the inferior region, and wherein the elastomeric wall thickness of the elastomeric seal-forming structure is thicker in the first intermediate region than in the second compliant region.

8. The cushion assembly of claim 7 , wherein the elastomeric seal-forming structure further comprises a second intermediate region adjacent the first intermediate region, and wherein the elastomeric wall thickness of the elastomeric seal-forming structure is thicker in the second intermediate region than in the first intermediate region.

9. The cushion assembly of claim 8 , wherein the first intermediate region intervenes between the inferior region and the second intermediate region.

10. The cushion assembly of claim 8 , wherein the second intermediate region is positioned between the elastomeric support portion and the first intermediate region.

11. The cushion assembly of claim 1 , wherein an elastomeric wall thickness of the elastomeric seal-forming structure in the first compliant region is the same as an elastomeric wall thickness of the elastomeric seal-forming structure in the second compliant region,

wherein the first compliant region of the elastomeric seal-forming structure extends to the elastomeric support portion, and the second compliant region of the elastomeric seal-forming structure does not extend to the elastomeric support portion,

wherein the blowout prevention system is in the form of a tubular structure,

wherein the more rigid support region is positioned at a location that is superior to the blowout prevention system,

wherein the elastomeric seal-forming structure further comprises an inferior region that includes the inferior tangent point, and wherein the elastomeric wall thickness of the elastomeric seal-forming structure in the inferior region is the same as the elastomeric wall thickness in the first compliant region,

wherein the elastomeric seal-forming structure further comprises a first intermediate region that extends from the second compliant region to the inferior region, and wherein the elastomeric wall thickness of the elastomeric seal-forming structure is thicker in the first intermediate region than in the second compliant region,

wherein the elastomeric seal-forming structure further comprises a second intermediate region adjacent the first intermediate region, and wherein the elastomeric wall thickness of the elastomeric seal-forming structure is thicker in the second intermediate region than in the first intermediate region,

wherein the first intermediate region intervenes between the inferior region and the second intermediate region, and

wherein the second intermediate region is positioned between the elastomeric support portion and the first intermediate region.

12. A patient interface comprising:

the cushion assembly of claim 1 ;

a rigid shell removably connected to the cushion assembly; and

headgear removably attached to the rigid shell.

13. A CPAP system comprising:

the patient interface according to claim 12 ;

a flow generator configured to pressurize a flow of gas; and

an air delivery tube configured to deliver the pressurized gas to the patient interface.

14. A cushion assembly for a patient interface for sealed delivery of a flow of air at a continuously positive pressure with respect to ambient air pressure to an entrance to a patient's airways including at least entrance of the patient's nares, wherein the patient interface is configured to maintain a therapy pressure in a range of about 4 cmH2O to about 30 cmH2O above ambient air pressure in use, throughout the patient's respiratory cycle, while the patient is sleeping, to ameliorate sleep disordered breathing, the cushion assembly comprising:

an elastomeric support portion;

an elastomeric seal-forming structure supported by the elastomeric support portion and being shaped to be bisected by a sagittal plane that includes a line tangent to the elastomeric seal-forming structure at a superior tangent point and at an inferior tangent point, the elastomeric support portion being more rigid than the elastomeric seal-forming structure; and

a chamber defined by the elastomeric support portion and the elastomeric seal-forming structure,

wherein the elastomeric seal-forming structure comprises an inner surface forming a boundary for the chamber and comprises an outer surface opposite the inner surface,

wherein the elastomeric seal-forming structure comprises a first compliant region that includes the superior tangent point and a second compliant region separated from the first compliant region by a support region that is more rigid than the first and second compliant regions,

wherein the more rigid support region extends to and is anchored by the elastomeric support portion, and wherein for every point in the rigid support region, a curvature of the inner surface follows a curvature of the outer surface,

wherein the outer surface of the elastomeric seal-forming structure in the first compliant region is saddle-shaped, wherein at least a portion of the outer surface of the elastomeric seal-forming structure in the second compliant region is dome-shaped, and wherein in the more rigid support region, the outer surface of the elastomeric seal-forming structure transitions from the saddle shape of the first compliant region to the dome shape in the second compliant region.

15. The cushion assembly of claim 14 , wherein the elastomeric seal-forming structure comprises an inferior region that includes the inferior tangent point, and wherein the outer surface of the elastomeric seal-forming structure in the inferior region is saddle-shaped.

16. The cushion assembly of claim 15 , wherein the elastomeric seal-forming structure comprises an intermediate region between the inferior region and the second compliant region, and wherein at least a portion of the outer surface of the elastomeric seal-forming structure in the intermediate region is cylinder shaped.

17. The cushion assembly of claim 16 , wherein the outer surface of the elastomeric seal-forming structure is dome-shaped in a portion of the intermediate region that is adjacent the inferior region.

18. The cushion assembly of claim 17 , wherein the dome-shaped portion of the intermediate region has a larger radius of curvature than the radius of curvature of the dome shape in the second compliant region.

19. The cushion assembly of claim 14 , further comprising a blowout prevention system with a first end anchored to the elastomeric support portion and a second end that is a continuation of a portion of the elastomeric seal-forming structure at which the outer surface is cylinder-shaped.

20. The cushion assembly of claim 19 , wherein the blowout prevention system is in the form of a tubular structure.

21. The cushion assembly of claim 19 , wherein the more rigid support region is positioned at a location that is superior to the blowout prevention system.

22. The cushion assembly of claim 19 , wherein the blowout prevention system is elastomeric.

23. The cushion assembly of claim 14 , further comprising a blowout prevention system with a first end anchored to the elastomeric support portion and a second end that is a continuation of a portion of the elastomeric seal-forming structure at which the outer surface is cylinder-shaped,

wherein the elastomeric seal-forming structure comprises an inferior region that includes the inferior tangent point, and wherein the outer surface of the elastomeric seal-forming structure in the inferior region is saddle-shaped,

wherein the elastomeric seal-forming structure comprises an intermediate region between the inferior region and the second compliant region, and wherein at least a portion of the outer surface of the elastomeric seal-forming structure in the intermediate region is cylinder shaped,

wherein the outer surface of the elastomeric seal-forming structure is dome-shaped in a portion of the intermediate region that is adjacent the inferior region,

wherein the dome-shaped portion of the intermediate region has a larger radius of curvature than the radius of curvature of the dome shape in the second compliant region,

wherein the blowout prevention system is in the form of a tubular structure,

wherein the more rigid support region is positioned at a location that is superior to the blowout prevention system, and

wherein the blowout prevention system is elastomeric.

24. A patient interface comprising:

the cushion assembly of claim 14 ;

a rigid shell removably connected to the cushion assembly; and

headgear removably attached to the rigid shell.

25. A CPAP system comprising:

the patient interface according to claim 24 ;

a flow generator configured to pressurize a flow of gas; and

an air delivery tube configured to deliver the pressurized gas to the patient interface.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2023
From: EVES, MATTHEW; NGA, LEMMY; RUMMERY, GERARD MICHAEL; SCHEINER, RUPERT CHRISTIAN
To: RESMED LIMITED
Reel/Frame 064040/0391 →
CHANGE OF NAME AND CHANGE OF ADDRESS Recorded Jun 23, 2023
From: RESMED LIMITED
To: RESMED PTY LTD
Reel/Frame 064960/0797 →
Priority Claims (1)
WO PCT/AU2016/050228 · Mar 24, 2016 · international
Continuity (5)
Continuation 17124578 · Dec 17, 2020
Continuation 15761168
Provisional Application 62377158 · Aug 19, 2016
Provisional Application 62222503 · Sep 23, 2015
Related Publication 20230338690A1 · Oct 26, 2023
References Cited (235)
US 4167185A · Lewis · 1979 [cited by applicant]
US 4782832A · Trimble et al. · 1988 [cited by applicant]
US 4907584A · McGinnis · 1990 [cited by applicant]
US 4944310A · Sullivan · 1990 [cited by applicant]
US 5540223A · Starr · 1996 [cited by applicant]
US 6467483B1 · Kopacko et al. · 2002 [cited by applicant]
US 6532959B1 · Berthon-Jones · 2003 [cited by applicant]
US 6581594B1 · Drew et al. · 2003 [cited by applicant]
US 7866944B2 · Kenyon et al. · 2011 [cited by applicant]
US 8636479B2 · Kenyon et al. · 2014 [cited by applicant]
US 8638014B2 · Sears et al. · 2014 [cited by applicant]
US 8733349B2 · Bath et al. · 2014 [cited by applicant]
US 9295800B2 · Davidson et al. · 2016 [cited by applicant]
US 10188820B2 · Edwards · 2019 [cited by applicant]
US 10926050B2 · Eves · 2021 [cited by examiner]
US 11052210B2 · Eves · 2021 [cited by applicant]
US 11707590B2 · Eves · 2023 [cited by examiner]
US 11717628B2 · Eves · 2023 [cited by examiner]
US 20010020474A1 · Hecker et al. · 2001 [cited by applicant]
US 20020043265A1 · Barnett · 2002 [cited by examiner]
US 20030019496A1 · Kopacko · 2003 [cited by examiner]
US 20030196655A1 · Ging et al. · 2003 [cited by applicant]
US 20030196656A1 · Moore · 2003 [cited by applicant]
US 20040118406A1 · Lithgow · 2004 [cited by applicant]
US 20060096598A1 · Ho et al. · 2006 [cited by applicant]
US 20060130844A1 · Ho et al. · 2006 [cited by applicant]
US 20060207599A1 · Busch et al. · 2006 [cited by applicant]
US 20070163594A1 · Ho et al. · 2007 [cited by applicant]
US 20070267017A1 · McAuley et al. · 2007 [cited by applicant]
US 20080006277A1 · Worboys · 2008 [cited by examiner]
US 20080110464A1 · Davidson · 2008 [cited by examiner]
US 20080302366A1 · McGinnis et al. · 2008 [cited by applicant]
US 20090044808A1 · Guney et al. · 2009 [cited by applicant]
US 20090050156A1 · Ng et al. · 2009 [cited by applicant]
US 20100000534A1 · Kooij et al. · 2010 [cited by applicant]
US 20100006101A1 · McAuley et al. · 2010 [cited by applicant]
US 20100170516A1 · Grane · 2010 [cited by applicant]
US 20110220110A1 · Frater et al. · 2011 [cited by applicant]
US 20120067349A1 · Barlow · 2012 [cited by applicant]
US 20120080035A1 · Guney · 2012 [cited by examiner]
US 20120138062A1 · Ho et al. · 2012 [cited by applicant]
US 20120204879A1 · Cariola et al. · 2012 [cited by applicant]
US 20120222680A1 · Eves et al. · 2012 [cited by applicant]
US 20120285464A1 · Birch et al. · 2012 [cited by applicant]
US 20130139822A1 · Gibson et al. · 2013 [cited by applicant]
US 20130146060A1 · Ho · 2013 [cited by applicant]
US 20130199537A1 · Formica · 2013 [cited by applicant]
US 20130340763A1 · Eifler et al. · 2013 [cited by applicant]
US 20140144448A1 · Eifler · 2014 [cited by applicant]
US 20140174446A1 · Prentice · 2014 [cited by examiner]
US 20140216462A1 · Law et al. · 2014 [cited by applicant]
US 20140224253A1 · Law et al. · 2014 [cited by applicant]
US 20140283843A1 · Eves et al. · 2014 [cited by applicant]
US 20140326243A1 · Znamenskiy · 2014 [cited by applicant]
US 20140326246A1 · Chodkowski et al. · 2014 [cited by applicant]
US 20140366886A1 · Chodkowski · 2014 [cited by examiner]
US 20150040911A1 · Davidson et al. · 2015 [cited by applicant]
US 20150090266A1 · Melidis · 2015 [cited by examiner]
US 20150144140A1 · Eury · 2015 [cited by applicant]
US 20150151067A1 · Eury · 2015 [cited by applicant]
US 20150246198A1 · Bearne et al. · 2015 [cited by applicant]
US 20150250971A1 · Bachelder et al. · 2015 [cited by applicant]
US 20150328421A1 · Stephenson · 2015 [cited by examiner]
US 20150328423A1 · Siew · 2015 [cited by applicant]
US 20150335845A1 · Baiko · 2015 [cited by applicant]
US 20150352306A1 · Scheiner · 2015 [cited by applicant]
US 20160082213A1 · Eifler · 2016 [cited by applicant]
US 20160103138A1 · Wo · 2016 [cited by applicant]
US 20160339196A1 · Bowsher · 2016 [cited by applicant]
US 20180185598A1 · Olsen · 2018 [cited by examiner]
US 20180272094A1 · Eves · 2018 [cited by applicant]
US 20180272095A1 · Eves et al. · 2018 [cited by applicant]
US 20180280649A1 · Eves · 2018 [cited by applicant]
US 20190151590A1 · Guney et al. · 2019 [cited by applicant]
US 20190217036A1 · Spear · 2019 [cited by examiner]
US 20200121880A1 · Olsen et al. · 2020 [cited by applicant]
US 20200246571A1 · Prentice et al. · 2020 [cited by applicant]
US 20200384230A1 · Eves et al. · 2020 [cited by applicant]
US 20210100970A1 · Eves et al. · 2021 [cited by applicant]
CA 2880224A1 · 2014 [cited by applicant]
CN 101198379A · 2008 [cited by applicant]
CN 101242866A · 2008 [cited by applicant]
CN 101301505A · 2008 [cited by applicant]
CN 103945890A · 2014 [cited by applicant]
CN 104587580A · 2015 [cited by applicant]
CN 104888328A · 2015 [cited by applicant]
DE 102007022639A1 · 2008 [cited by applicant]
DE 202004021758U1 · 2010 [cited by applicant]
EP 1258266A1 · 2002 [cited by applicant]
EP 1982740A2 · 2008 [cited by applicant]
EP 2145645A1 · 2010 [cited by applicant]
EP 3095478A1 · 2016 [cited by applicant]
JP 2008518718A · 2008 [cited by applicant]
JP 2008526391A · 2008 [cited by applicant]
JP 2009195758A · 2009 [cited by applicant]
JP 2012530561 · 2012 [cited by applicant]
JP 2014517735 · 2014 [cited by applicant]
JP 2014520587 · 2014 [cited by applicant]
JP 2015126945 · 2015 [cited by applicant]
JP 2016504940 · 2016 [cited by applicant]
JP 2017527365 · 2017 [cited by applicant]
JP 2018527155 · 2018 [cited by applicant]
JP 2018527156 · 2018 [cited by applicant]
WO 9804310 · 1998 [cited by applicant]
WO 9818514A1 · 1998 [cited by applicant]
WO 9834665 · 1998 [cited by applicant]
WO 0078381 · 2000 [cited by applicant]
WO 2004022146A1 · 2004 [cited by applicant]
WO 2004073778 · 2004 [cited by applicant]
WO 2005063328 · 2005 [cited by applicant]
WO 2006074513 · 2006 [cited by applicant]
WO 2006130903 · 2006 [cited by applicant]
WO 2007009182A1 · 2007 [cited by applicant]
WO 2009052560 · 2009 [cited by applicant]
WO 2010009877A1 · 2010 [cited by applicant]
WO 2010135785 · 2010 [cited by applicant]
WO 2010148453A1 · 2010 [cited by applicant]
WO 2012140514A1 · 2012 [cited by applicant]
WO 2012171072A1 · 2012 [cited by applicant]
WO 2013020167A1 · 2013 [cited by applicant]
WO 2014038959A1 · 2014 [cited by applicant]
WO 2014062070A1 · 2014 [cited by applicant]
WO 2014091360A1 · 2014 [cited by applicant]
WO 2014110626A1 · 2014 [cited by applicant]
WO 2014117227A1 · 2014 [cited by applicant]
WO 2014117227A9 · 2014 [cited by applicant]
WO 2014141029A1 · 2014 [cited by applicant]
WO 2014155329A2 · 2014 [cited by applicant]
WO 2014183167A1 · 2014 [cited by applicant]
WO 2015009172A1 · 2015 [cited by applicant]
WO 2015013761A1 · 2015 [cited by applicant]
WO 2015070289A1 · 2015 [cited by applicant]
WO 2015193821A1 · 2015 [cited by applicant]
WO 2016032343A1 · 2016 [cited by applicant]
WO 2016041019A1 · 2016 [cited by applicant]
WO 2016097948 · 2016 [cited by applicant]
WO 2016149769A2 · 2016 [cited by applicant]
WO 2017049361A1 · 2017 [cited by applicant]
Examination Report dated Jul. 12, 2023 issued in New Zealand Application No. 780367 (3 pages). [cited by applicant]
Examination Report dated Jul. 25, 2023 issued in New Zealand Application No. 780370 (3 pages). [cited by applicant]
Examination Report dated Jul. 25, 2023 issued in New Zealand Application No. 780375 (3 pages). [cited by applicant]
Examination Report dated Jul. 26, 2023 issued in New Zealand Application No. 780514 (3 pages). [cited by applicant]
Examination Report dated Jul. 26, 2023 issued in New Zealand Application No. 780366 (3 pages). [cited by applicant]
Notice of Grant dated Aug. 16, 2023 issued in Chinese Application No. 201680066661.1 (4 pages). [cited by applicant]
Examination Report dated Aug. 22, 2023 issued in New Zealand Application No. 780258 (4 pages). [cited by applicant]
Examination Report dated Aug. 22, 2023 issued in New Zealand Application No. 780440 (4 pages). [cited by applicant]
Examination Report dated Aug. 22, 2023 issued in New Zealand Application No. 780446 (3 pages). [cited by applicant]
Examination Report dated Aug. 22, 2023 issued in New Zealand Application No. 780508 (4 pages). [cited by applicant]
Office Action dated Sep. 11, 2023 issued in Japanese Application No. 2022-186547 with English translation (4 pages). [cited by applicant]
Examination Report dated Sep. 20, 2023 issued in New Zealand Application No. 740579 (3 pages). [cited by applicant]
Office Action dated Apr. 11, 2024 issued in U.S. Appl. No. 17/559,850 (27 pages). [cited by applicant]
Patent Examination Report 2 dated Apr. 10, 2024 issued in New Zealand Application No. 780258 (3 pages). [cited by applicant]
Patent Examination Report 2 dated Apr. 10, 2024 issued in New Zealand Application No. 780508 (3 pages). [cited by applicant]
Patent Examination Report 2 dated Apr. 10, 2024 issued in New Zealand Application No. 780446 (3 pages). [cited by applicant]
Patent Examination Report 5 dated May 17, 2024 issued in New Zealand Application No. 779744 (2 pages). [cited by applicant]
Patent Examination Report 4 dated May 13, 2024 issued in New Zealand Application No. 740579 (3 pages). [cited by applicant]
Patent Examination Report 3 dated Jun. 7, 2024 issued in New Zealand Application No. 780421 (4 pages). [cited by applicant]
Patent Examination Report 3 dated Jun. 11, 2024 issued in New Zealand Application No. 780429 (3 pages). [cited by applicant]
Extended European Search Report dated Jun. 19, 2024 issued in European Application No. 24150060.2 (6 pages). [cited by applicant]
Examination Report dated May 12, 2023 issued in New Zealand Application No. 778730 (3 pages). [cited by applicant]
Examination Report dated May 12, 2023 issued in New Zealand Application No. 740770 (3 pages). [cited by applicant]
Notice of Allowance dated Apr. 24, 2023 issued in Japanese Application No. 2021-175495 (3 pages). [cited by applicant]
Examination Report dated Nov. 25, 2022 issued in New Zealand Application No. 740229 (3 pages). [cited by applicant]
Extended European Search Report dated Oct. 11, 2022 issued in European Application No. 22176256.0 (10 pages). [cited by applicant]
Notice of Allowance dated Oct. 24, 2022 issued in Japanese Application No. 2021-119633 (3 pages). [cited by applicant]
Office Action dated Oct. 3, 2022 issued in Japanese Application No. 20210175495 with English translation (15 pages). [cited by applicant]
Office Action dated Oct. 28, 2022 issued in U.S. Appl. No. 17/002,244 (28 pages). [cited by applicant]
Extended European Search Report dated Jul. 18, 2022 issued in European Application No. 22150043.2 (9 pages). [cited by applicant]
Office Action dated Sep. 5, 2022 issued in Japanese Application No. 2021-133423 with English translation (16 pages). [cited by applicant]
Office Action dated May 9, 2022 issued in Japanese Application No. 2021-119633 with English translation (15 pages). [cited by applicant]
Examination Report dated Jul. 5, 2022 issued in New Zealand Application No. 740229 (3 pages). [cited by applicant]
Extended European Search Report dated Jul. 18, 2022 issued in European Application No. 21214534.6 (8 pages). [cited by applicant]
Examination Report dated Jul. 12, 2022 issued in New Zealand Application No. 769765 (3 pages). [cited by applicant]
Office Action dated Apr. 28, 2021 issued in Chinese Application No. 201680066661.1 with English translation (16 pages). [cited by applicant]
Office Action dated Jun. 28, 2021 issued in Japanese Application No. 2018-533976 with English translation (6 pages). [cited by applicant]
Notice of Allowance dated Jun. 21, 2021 issued in Japanese Application No. 2018-533977 (3 pages). [cited by applicant]
Notice of Allowance dated Jul. 19, 2021 issued in Japanese Application No. 2018-533978 (3 pages). [cited by applicant]
Office Action dated Dec. 8, 2020 issued in Chinese Application No. 201680066661.1 with English translation (11 pages). [cited by applicant]
Office Action dated Oct. 5, 2020 issued in Japanese Application No. 2018-533976 with English translation (8 pages). [cited by applicant]
Office Action dated Oct. 19, 2020 issued in Japanese Application No. 2018-533978 with English translation (8 pages). [cited by applicant]
Office Action dated Oct. 26, 2020 issued in European Application No. 16847658.8 (5 pages). [cited by applicant]
Notice of Reasons for Rejection dated Oct. 12, 2020 issued in Application No. 2018-533977 with English translation (15 pages). [cited by applicant]
Office Action dated Oct. 15, 2020 issued in European Application No. 16847657.0 (5 pages). [cited by applicant]
Office Action dated Jan. 28, 2020 issued in U.S. Appl. No. 15/759,985 (17 pages). [cited by applicant]
Office Action dated Nov. 27, 2019 issued in U.S. Appl. No. 15/762,150 (28 pages). [cited by applicant]
Office Action dated Feb. 3, 2020 issued in Chinese Application No. 201680056156.9 with English translation (15 pages). [cited by applicant]
Office Action dated Feb. 3, 2020 issued in Chinese Application No. 201680061003.3 with English translation (21 pages). [cited by applicant]
Extended European Search Report dated May 10, 2019 issued in European Application No. 16847657.0 (8 pages). [cited by applicant]
International Search Report for PCT/AU2016/050896, mailed Jan. 3, 2017, 9 pages. [cited by applicant]
Written Opinion for PCT/AU2016/050896, mailed Jan. 3, 2017, 7 pages. [cited by applicant]
International Preliminary Report on Patentability for PCT/AU2016/050896, mailed Jan. 9, 2018, 189 pages. [cited by applicant]
International Search Report for PCT/AU2016/050894, mailed Dec. 12, 2016, 7 pages. [cited by applicant]
Written Opinion of the ISA for PCT/AU2016/050894, mailed Dec. 12, 2016, 4 pages. [cited by applicant]
Written Opinion of the IPEA for PCT/AU2016/050894, mailed Oct. 27, 2017, 6 pages. [cited by applicant]
International Preliminary Report on Patentability for PCT/AU2016/050894, mailed Jan. 16, 2018, 11 pages. [cited by applicant]
Extended European Search Report dated May 13, 2019 issued in European Application No. 16847658.8 (11 pages). [cited by applicant]
Partial Supplementary European Search Report dated May 13, 2019 issued in European Application No. 16847659.6 (15 pages). [cited by applicant]
International Search Report for PCT/AU2016/050895, mailed Jan. 12, 2017, 15 pages. [cited by applicant]
Written opinion of the ISA PCT/AU2016/050895, mailed Jan. 12, 2017, 12 pages. [cited by applicant]
Written Opinion of the IPEA for PCT/AU2016/050895, mailed Oct. 23, 2017, 10 pages. [cited by applicant]
International Preliminary Report on Patentability for PCT/AU2016/050895, mailed Jan. 22, 2018, 221 pages. [cited by applicant]
West, John. “Respiratory Physiology”, Lippincott Williams & Wilkins, 9 [cited by applicant]
Examination Reoort dated Jul. 3, 2024 issued in New Zealand Application No. 780446 (4 pages). [cited by applicant]
Examination Report dated Jul. 10, 2024 issued in New Zealand Application No. 780446 (1 pages). [cited by applicant]
Notification of Grant dated Jul. 17, 2024 issued in Chinese Application No. 202110424693.7 (4 pages). [cited by applicant]
Notification of Grant dated Jul. 30, 2024 issued in Chinese Application No. 202011132244.7 (4 pages). [cited by applicant]
Office Action dated Jul. 29, 2024 issued in Japanese Application No. 2023-84810 with English translation (9 pages). [cited by applicant]
Office Action dated Aug. 5, 2024 issued in Japanese Application No. 2023-204787 with English translation (6 pages). [cited by applicant]
Examination Report dated Jan. 10, 2024 issued in New Zealand Application No. 779758 (4 pages). [cited by applicant]
Notice of Allowance dated Jan. 29, 2024 issued in Japanese Application No. 2022-186547 (3 pages). [cited by applicant]
Examination Report dated Feb. 12, 2024 issued in New Zealand Application No. 740579 (5 pages). [cited by applicant]
Examination Report dated Feb. 14, 2024 issued in New Zealand Application No. 780370 (3 pages). [cited by applicant]
Examination Report dated Feb. 14, 2024 issued in New Zealand Application No. 780375 (3 pages). [cited by applicant]
Examination Report dated Feb. 13, 2024 issued in New Zealand Application No. 780294 (5 pages). [cited by applicant]
Examination Report dated Feb. 15, 2024 issued in New Zealand Application No. 780421 (6 pages). [cited by applicant]
Examination Report dated Feb. 15, 2024 issued in New Zealand Application No. 780429 (6 pages). [cited by applicant]
Examination Report dated Feb. 13, 2024 issued in New Zealand Application No. 780513 (3 pages). [cited by applicant]
Office Action dated Mar. 8, 2024 issued in Chinese Application No. 202110424693.7 with English translation (9 pagees). [cited by applicant]
Office Action dated Feb. 13, 2024 issued in Japanese Application No. 2023-084810 with English translation (7 pages). [cited by applicant]
Office Action dated Mar. 13, 2024 issued in Chinese Application No. 202011132244.7 with English translation (11 pagees). [cited by applicant]
Examination Report dated Feb. 13, 2024 issued in New Zealand Application No. 779744 (4 pages). [cited by applicant]
Office Action dated Nov. 14, 2024 issued in U.S. Appl. No. 18/329,008 citing US 2015/0013682 A1 (38 pages). [cited by applicant]
Extended European Search Report dated Dec. 23, 2024 issued in European Application No. 24188721.5 (9 pages). [cited by applicant]
Extended European Search Report dated Nov. 27, 2024 issued in European Application No. 24178607.8 (14 pages). [cited by applicant]
Office Action dated Oct. 28, 2024 issued in Japanese Application No. 2024-027329 with English translation (7 pages). [cited by applicant]
Deadline for Counterstatement dated Nov. 6, 2024 issued in New Zealand Application No. 780421 (2 pages). [cited by applicant]
Notice of Opposition and Statement of Case dated Nov. 5, 2024 filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 780421 (1 page). [cited by applicant]
Notice of Opposition dated Nov. 5, 2024 filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 780421 (3 pages). [cited by applicant]
Statement of Case dated Nov. 5, 2024 filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 780421 (11 pages). [cited by applicant]
Extension of Time to Oppose Granted dated Oct. 9, 2024 issued in New Zealand Application No. 780294 (1 page). [cited by applicant]
Deadline for Counterstatement dated Nov. 6, 2024 issued in New Zealand Application No. 780294 (1 page). [cited by applicant]
Request for Extension of Time to Oppose dated Oct. 4, 2024 filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 780294 (1 page). [cited by applicant]
Notice of Opposition and Statement of Case dated Nov. 5, 2024 filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 780294 (1 page). [cited by applicant]
Notice of Opposition dated Nov. 5, 2024 filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 780294 (3 pages). [cited by applicant]
Statement of Case dated Nov. 5, 2024 filed by Fisher & Paykel Healthcare Limited in New Zealand Application No. 780294 (12 pages). [cited by applicant]